Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Pharma packaging manufacturer presents pharma-grade sustainable plastic packaging solution, a bottle completely produced with a pharma-grade and food-grade rPET
May 10, 2019
By: Tim Wright
Editor-in-Chief, Contract Pharma
The Italian pharma packaging manufacturer, Bormioli Pharma, is promoting ‘green’ plastic solutions compliant with the European Pharmacopoeia and also making sustainability a key topic of its new corporate innovation strategy. Specifically, Bormioli has developed a new product: a bottle made of 100% pharma-grade rPET, which features the same performance of its virgin counterpart (PET). According to the company, the high quality of its post-consumer recycled PET makes it transformable exactly like the virgin PET, allowing the creation of a highly-customized solution according to customer needs. The product has also been rated suitable for food contact, featuring an excellent transparency, low levels of contamination, as well as physical and mechanical properties comparable to virgin PET. The company has also developed cups and spoons in food-grade PLA, and fully degradable within 60 days in industrial compost facilities. In addition, the company said its goal is to obtain by 2023 pharma-grade certification for a wide range of solutions currently used in the nutraceutical and cosmetics industry. Among these are green polyethylene containers made with 100% bio-based plastic, and BioPET bottles, containing up to 30% of material coming from renewable sources. “Sustainability is a hot topic on the public agenda, but it is still not considered a requirement by the pharma industry,” said Fabio Silvestri, head of product strategy and planning, Bormioli Pharma. “We are pioneers in this matter and we aim to promote sustainability throughout the pharma value chain, partnering with companies to develop sustainable programs as well as customized and compliant solutions with an open innovation approach. This means involving clients, as well as end users, startups, research centers and universities in our R&D programs, creating a porous environment that is able to generate new value for all the stakeholders.” Developing greener plastic solutions is just a part of a broader sustainability strategy by Bormioli, with the company setting new corporate sustainability targets to be achieved within the 2020-2023 strategic plan, such as: • Increasing the use of recycled materials, from 2% to 30% throughout the company’s packaging solutions; • Replacing single-use packaging with fully biodegradable solutions, compatibly with future market requirements; and • Enhancing energy saving in production, on new plastic injection machines (-50%), plant lighting (-30%) and on new glass furnaces (-20%).
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !